Literature DB >> 30457050

Advancement in Microbial Cheminformatics.

Anuraj Nayarisseri1,2, Elizabeth Anne Hood3.   

Abstract

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Mesh：

Substances：

Year:  2018        PMID： 30457050     DOI： 10.2174/1568026619666181120121528

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN： 1568-0266            Impact factor:   3.295


  4 in total

1.  Structure-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation of VEGF inhibitors for the clinical treatment of Ovarian Cancer.

Authors:  Sourav Mukherjee; Mohnad Abdalla; Manasi Yadav; Maddala Madhavi; Anushka Bhrdwaj; Ravina Khandelwal; Leena Prajapati; Aravind Panicker; Aashish Chaudhary; Ashraf Albrakati; Tajamul Hussain; Anuraj Nayarisseri; Sanjeev Kumar Singh
Journal:  J Mol Model       Date:  2022-03-24       Impact factor: 1.810

2.  Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis.

Authors:  Divya Jain; Trishang Udhwani; Shreshtha Sharma; Aishwarya Gandhe; Palugulla Bhaskar Reddy; Anuraj Nayarisseri; Sanjeev Kumar Singh
Journal:  Bioinformation       Date:  2019-02-28

3.  Identification of High-Affinity Small Molecule Targeting IDH2 for the Clinical Treatment of Acute Myeloid Leukemia.

Authors:  Jajoriya Sweta; Ravina Khandelwal; Sivaraj Srinitha; Rashi Pancholi; Ritu Adhikary; Meer Asif Ali; Anuraj Nayarisseri; Sugunakar Vuree; Sanjeev Kumar Singh
Journal:  Asian Pac J Cancer Prev       Date:  2019-08-01

4.  Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach.

Authors:  Mohini Yadav; Ravina Khandelwal; Urvy Mudgal; Sivaraj Srinitha; Natasha Khandekar; Anuraj Nayarisseri; Sugunakar Vuree; Sanjeev Kumar Singh
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.